SARS-CoV-2Omicron

Revansiddha H Katte1, Yuanyun Ao1, Wang Xu1

  • 1Department of Cellular and Molecular Biology, School of Medicine, University of Texas at Tyler Health Science Center, Tyler, TX 75708, USA.

Viruses
|March 28, 2024
PubMed
概括

最近的Omicron亚型,如XBB.1.5,在人类肺细胞中没有显著的进入优势,而不是早期的菌株. 从改变的尖端蛋白序列的免疫逃避,而不是细胞进入效率,可能驱动病毒健康.